
Altimmune (ALT) and Rocket Lab Corp (RKLB) experienced notable options trading volume, with 79.6% and 79.3% of their respective average daily trading volumes represented in options contracts. Specifically, the $7 strike call option for ALT expiring June 20, 2025, and the $30 strike call option for RKLB with the same expiration date saw particularly high activity, indicating potential speculative interest in these price levels.
Altimmune (ALT) and Rocket Lab Corp (RKLB) are both experiencing significant options market activity, with total options volume representing 79.6% and 79.3% of their respective average daily share trading volumes. This elevated activity is concentrated in specific long-dated call options, indicating targeted speculation. For Altimmune, a notable volume of 2,728 contracts was traded for the $7 strike call option expiring in June 2025. Similarly, Rocket Lab saw heavy trading in its June 2025 call options, with 14,099 contracts changing hands at the $30 strike price. The focus on these far-dated call options suggests that some market participants are positioning for a substantial appreciation in the share prices of both companies over the next year, establishing specific price levels that are attracting speculative interest.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
neutral
Sentiment Score
0.00
Ticker Sentiment